Boosting the acceptance of F-FET PET for image-guided treatment planning with a multi-centric prospective trial.
作者信息
Langen Karl-Josef, Galldiks Norbert, Lohmann Philipp, Mottaghy Felix M
机构信息
Institute of Neuroscience and Medicine (INM-3, INM-4), Forschungszentrum Juelich, Juelich, Germany.
Department of Nuclear Medicine, RWTH Aachen University Hospital, Pauwelsstraße 30, D-52074, Aachen, Germany.
出版信息
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3817-3819. doi: 10.1007/s00259-023-06426-7.
Abstract
摘要
相似文献
1
Boosting the acceptance of F-FET PET for image-guided treatment planning with a multi-centric prospective trial.
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3817-3819. doi: 10.1007/s00259-023-06426-7.
2
[F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial.
BMJ Open. 2023 Aug 4;13(8):e071327. doi: 10.1136/bmjopen-2022-071327.
3
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
J Neurosurg. 2005 Feb;102(2):318-27. doi: 10.3171/jns.2005.102.2.0318.
4
Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
World Neurosurg. 2016 May;89:230-9. doi: 10.1016/j.wneu.2016.01.085. Epub 2016 Mar 9.
5
Radiotherapy target volume definition in newly diagnosed high grade glioma using F-FET PET imaging and multiparametric perfusion MRI: A prospective study (IMAGG).
Radiother Oncol. 2020 Sep;150:164-171. doi: 10.1016/j.radonc.2020.06.025. Epub 2020 Jun 21.
6
The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions.
Cancer Imaging. 2014 Jun 25;14(1):25. doi: 10.1186/1470-7330-14-25.
7
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):22-33. doi: 10.1007/s00259-012-2251-4. Epub 2012 Sep 29.
8
FET-PET for malignant glioma treatment planning.
Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30.
9
Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Radiother Oncol. 2013 Dec;109(3):487-92. doi: 10.1016/j.radonc.2013.06.043. Epub 2013 Aug 13.
10
(18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
World Neurosurg. 2016 May;89:420-6. doi: 10.1016/j.wneu.2016.02.032. Epub 2016 Feb 15.
本文引用的文献
1
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06.
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3970-3981. doi: 10.1007/s00259-023-06371-5. Epub 2023 Aug 11.
2
Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
J Nucl Med. 2023 Oct;64(10):1594-1602. doi: 10.2967/jnumed.123.265725. Epub 2023 Aug 10.
3
Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma.
Nat Commun. 2023 Jul 29;14(1):4572. doi: 10.1038/s41467-023-39731-8.
4
Amino Acid PET in Neurooncology.
J Nucl Med. 2023 May;64(5):693-700. doi: 10.2967/jnumed.122.264859. Epub 2023 Apr 13.
5
Two Decades of Brain Tumour Imaging with O-(2-[F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience.
Cancers (Basel). 2022 Jul 8;14(14):3336. doi: 10.3390/cancers14143336.
6
Initial Results of a Phase 2 Trial of F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma.
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1383-1395. doi: 10.1016/j.ijrobp.2021.03.032. Epub 2021 Mar 23.
7
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.
Neuro Oncol. 2021 Jun 1;23(6):881-893. doi: 10.1093/neuonc/noab013.
8
Early Treatment Response Assessment Using F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy.
J Nucl Med. 2021 Jul 1;62(7):918-925. doi: 10.2967/jnumed.120.254243. Epub 2020 Nov 6.
9
Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1458-1467. doi: 10.1007/s00259-019-04656-2. Epub 2020 Jan 9.
10
PET imaging in patients with brain metastasis-report of the RANO/PET group.
Neuro Oncol. 2019 May 6;21(5):585-595. doi: 10.1093/neuonc/noz003.
Zotero 插件